Financial results - URO - ONCO MED S.R.L.

Financial Summary - Uro - Onco Med S.r.l.
Unique identification code: 40580144
Registration number: J05/537/2019
Nace: 8622
Sales - Ron
83.110
Net Profit - Ron
72.311
Employees
1
Open Account
Company Uro - Onco Med S.r.l. with Fiscal Code 40580144 recorded a turnover of 2024 of 83.110, with a net profit of 72.311 and having an average number of employees of 1. The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Uro - Onco Med S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - 6.915 2.358 22.798 23.268 31.856 83.110
Total Income - EUR - - - - 6.915 2.358 22.798 24.130 32.954 83.110
Total Expenses - EUR - - - - 0 88 1.135 1.121 9.039 9.357
Gross Profit/Loss - EUR - - - - 6.915 2.269 21.664 23.009 23.915 73.752
Net Profit/Loss - EUR - - - - 6.708 2.199 20.980 22.445 23.596 72.311
Employees - - - - 0 0 0 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 162.4%, from 31.856 euro in the year 2023, to 83.110 euro in 2024. The Net Profit increased by 48.847 euro, from 23.596 euro in 2023, to 72.311 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Uro - Onco Med S.r.l.

Rating financiar

Financial Rating -
URO - ONCO MED S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Uro - Onco Med S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Uro - Onco Med S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Uro - Onco Med S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Uro - Onco Med S.r.l. - CUI 40580144

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - 0 0 0 1.727 433 0
Current Assets - - - - 6.957 8.841 11.378 26.524 42.928 79.298
Inventories - - - - 0 0 0 0 0 0
Receivables - - - - 6.915 6.784 8.819 24.349 36.079 75.850
Cash - - - - 42 2.056 2.558 2.175 6.848 3.448
Shareholders Funds - - - - 6.750 8.829 9.873 22.494 32.211 72.351
Social Capital - - - - 42 41 40 41 40 40
Debts - - - - 207 12 1.505 5.758 11.150 6.947
Income in Advance - - - - 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 79.298 euro in 2024 which includes Inventories of 0 euro, Receivables of 75.850 euro and cash availability of 3.448 euro.
The company's Equity was valued at 72.351 euro, while total Liabilities amounted to 6.947 euro. Equity increased by 40.320 euro, from 32.211 euro in 2023, to 72.351 in 2024.

Risk Reports Prices

Reviews - Uro - Onco Med S.r.l.

Comments - Uro - Onco Med S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.